Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its Retoxin® (recombinant botulinum toxin type A, project ...
The FDA issued a complete response letter regarding AbbVie’s biologics license application for trenibotulinumtoxinE, a ...
AbbVie Inc. (NYSE:ABBV) is one of the best low volatility stocks to invest in right now. AbbVie Inc. (NYSE:ABBV) announced on ...
A toxin much like the one that causes botulism has unexpectedly turned up in a completely different type of bacteria - Enterococcus. Where it came from is unclear, but the finding is concerning ...
DENVER — Botulinum toxin A, commonly known as Botox, has an antidepressive effect when injected between the eyebrows that continues beyond the cosmetic effects of the injection, according to the ...
The purpose of this study is to evaluate the efficacy and safety of botulinum toxin injection as a primary treatment for strabismus in a cohort of patients with nasopharyngeal carcinoma (NPC)-related ...
The use of toxin botulinum-A is one of the most rapidly growing areas in cosmetic dermatology. There is always news about this incredible substance. There are new indications, new techniques, and new ...
New research from the University of Wisconsin School of Medicine and Public Health and Scripps Research Institute shows how the astonishingly powerful botulinum toxin uses a unuque navigational ...
Please provide your email address to receive an email when new articles are posted on . Some botulinum toxin type A injection formulations have a faster onset, whereas others were shown to last longer ...
The alternative text for this image may have been generated using AI. Figure 3: Site-directed mutagenesis analysis of the toxin-receptor binding site in BoNT/B and in the luminal domains of Syt-I and ...
PHOENIX -- Botulinum toxin injections offered relief from sialorrhea, or excessive saliva production, in patients with amyotrophic lateral sclerosis (ALS), according to a small study. The ...
CHONGQING, China, April 28, 2026 /PRNewswire/ -- Chongqing Claruvis Pharmaceutical Co., Ltd. recently announced that the China's National Medical Products Administration (NMPA) has approved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results